STIM
Neuronetics, Inc.
Latest Form 4:Purchase$44KbyChernett Jorey (10% Owner) · filed Aug 17, 2026
Neuronetics, Inc. (STIM) has 44 SEC Form 4 filings (55 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Aug 17, 2026.
The most active filer is 10% Owner Chernett Jorey with 14 filings. Insiders have net bought $4.7M over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Daniel L. Reuvers
- Employees:658
- HQ:Malvern, PA, US
- IPO:2018-06-28
Insider Buying
$4.8M
reported purchases (SEC code P)
Insider Selling
$282K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$224.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 14,000 | $44K | Aug 17 | SEC ↗ | |
| 10% Owner | Purchase | 35,000 | $62K | Jul 15 | SEC ↗ | |
| Former EVP, CFO and Treasurer | Sale | 25,000 | $34K | May 21 | SEC ↗ | |
| 10% Owner | Purchase | 100,000 | $117K | May 20 | SEC ↗ | |
| 10% Owner | Purchase | 475,000 | $637K | May 13 | SEC ↗ | |
| 10% Owner | Purchase | 100,000 | $158K | Apr 22 | SEC ↗ | |
| 10% Owner | Purchase | 100,000 | $151K | Apr 22 | SEC ↗ | |
| 10% Owner | Purchase | 385,442 | $482K | Mar 30 | SEC ↗ | |
| 10% Owner | Purchase | 500,000 | $675K | Mar 30 | SEC ↗ | |
| 10% Owner | Purchase | 125,000 | $175K | Mar 27 | SEC ↗ | |
| 10% Owner | Purchase | 25,000 | $36K | Mar 27 | SEC ↗ | |
| Former Officer & Director | Sale | 46,289 | $62K | Mar 24 | SEC ↗ | |
| EVP, CLO and CS | Sale | 16,005 | $21K | Mar 24 | SEC ↗ | |
| 10% Owner | Purchase | 169,472 | $239K | Mar 23 | SEC ↗ | |
| 10% Owner | Purchase | 607,400 | $820K | Mar 20 | SEC ↗ | |
| 10% Owner | Purchase | 450,000 | $599K | Mar 20 | SEC ↗ | |
| 10% Owner | Purchase | 531,000 | $616K | Mar 18 | SEC ↗ | |
| EVP, CLO and CS | Sale | 609 | $816 | Mar 6 | SEC ↗ | |
| EVP, CLO and CS | Sale | 3,427 | $5K | Feb 27 | SEC ↗ | |
| President and CEO | Sale | 8,452 | $11K | Feb 27 | SEC ↗ | |
| EVP, CLO and CS | Sale | 14,120 | $23K | Feb 18 | SEC ↗ | |
| President and CEO | Sale | 33,847 | $56K | Feb 18 | SEC ↗ | |
Sullivan Keith JFirst filing | President and CEO | Sale | 40,976 | $64K | Feb 12 | SEC ↗ |
MACAN WILLIAM ANDREWFirst filing | EVP, CLO and CS | Sale | 3,485 | $5K | Feb 12 | SEC ↗ |
Related companies
Neuronetics, Inc. is in the Healthcare sector.